Christof Burek

Christof Burek

UNVERIFIED PROFILE

Are you Christof Burek?   Register this Author

Register author
Christof Burek

Christof Burek

Publications by authors named "Christof Burek"

Are you Christof Burek?   Register this Author

11Publications

212Reads

9Profile Views

C-terminal diversity within the p53 family accounts for differences in DNA binding and transcriptional activity.

Nucleic Acids Res 2008 Apr 11;36(6):1900-12. Epub 2008 Feb 11.

Department of Hematology, Oncology and Immunology, Institute for Molecular Biology and Tumor Research, Philipps-University Marburg, 35033 Marburg, Germany.

View Article

Download full-text PDF

Source
https://academic.oup.com/nar/article-lookup/doi/10.1093/nar/
Publisher Site
http://dx.doi.org/10.1093/nar/gkn044DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2330244PMC
April 2008

Potentially oncogenic B-cell activation-induced smaller isoforms of FOXP1 are highly expressed in the activated B cell-like subtype of DLBCL.

Blood 2008 Mar 12;111(5):2816-24. Epub 2007 Dec 12.

Nuffield Department of Clinical Laboratory Sciences, University of Oxford, John Radcliffe Hospital, Headington, Oxford, United Kingdom.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2007-09-115113DOI Listing
March 2008

Diagnostic and prognostic significance of gene expression profiling in lymphomas.

APMIS 2007 Oct;115(10):1135-46

Institute of Pathology, University of Würzburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1600-0463.2007.apm_867.xml.xDOI Listing
October 2007

p53 family members in myogenic differentiation and rhabdomyosarcoma development.

Cancer Cell 2006 Oct;10(4):281-93

Molecular Tumor Biology Group, Rudolf-Virchow-Center, DFG Research Center for Experimental Biomedicine, University of Würzburg, 97078 Würzburg, Germany.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S153561080600280
Publisher Site
http://dx.doi.org/10.1016/j.ccr.2006.08.024DOI Listing
October 2006

Anticancer drugs of tomorrow: apoptotic pathways as targets for drug design.

Drug Discov Today 2003 Jan;8(2):67-77

Institute of Experimental Dermatology, Röntgenstr. 21, University of Münster, D-48149 Münster, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s1359-6446(02)02563-1DOI Listing
January 2003